In a follow-up analysis, Zhao et al. showed significant survival differences in LUAD, breast, ovarian, and mesothelioma cancers between the high and low-risk groups defined by the ratio of expression levels of the PSG genes between the tumor and normal tissue from the Genotype-Tissue Expression [10]. The gene discussed is PSG5; the disease is neoplasm.